Jiangsu Nhwa Pharmaceutical Co., Ltd. Jiangsu Nhwa Pharmaceutical Co., Ltd.

Jiangsu Nhwa Pharmaceutical Co., Ltd.

002262

Rang in aandelen #4678
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Aandeelprijs
$3.19
Marktkapitalisatie
$3.23B
Verandering (1 dag)
1.38%
Verandering (1 jaar)
-12.82%
Land
CN
Handel Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)

Categorie

Healthcare
Dividendrendementgeschiedenis voor Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Het dividendrendement (TTM) van Jiangsu Nhwa Pharmaceutical Co., Ltd. (aandelsymbool: 002262) per 2023-12-31 is: 0.73%
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.82%
Dividendrendementgeschiedenis van Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262) van 2005 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
2026 (TTM) 1.89% 44.27%
2024 1.31% 79.45%
2023 0.73% -9.88%
2022 0.81% 26.56%
2021 0.64% 1.59%
2020 0.63% -4.55%
2019 0.66% -9.59%
2018 0.73% 121.21%
2017 0.33% 6.45%
2016 0.31% 6.90%
2015 0.29% -23.68%
2014 0.38% -2.56%
2013 0.39% -22.00%
2012 0.50% -29.58%
2011 0.71% 69.05%
2010 0.42% -53.85%
2009 0.91% -22.88%
2008 1.18% 93.44%
2007 0.61% -72.40%
2006 2.21% 190.79%
2005 0.76% 0.00%
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten